Uncategorized
Tesamorelin
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) that stimulates endogenous GH secretion.
Free shipping
Free Damage Protection
Secure checkout
Research Applications
Third Party Tested by Freedom Diagnostics
Study of GH axis regulation
Evaluation of visceral adipose tissue reduction
Investigation of IGF-1 mediated metabolic effects
Technical Information
Technical specifications
Product Specifications
Class
GHRH analog peptide
FDA status
Approved (HIV-associated lipodystrophy)
Mechanism
Pituitary GH stimulation
🧊 Storage Requirements
Handling Information
Refrigeration required
Reconstituted solution used promptly
Related Articles
Peer-reviewed research
Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation
2010 • PMID: 20101189
⚠️ Compliance
Approved drug; off-label/research use governed by regulations
All the research peptides you need, with the peace of mind and research community at your fingertips.
Support FAQ
Quick answers to common questions
What is Tesamorelin and how does it work?
Tesamorelin is a lab-made peptide that signals the body to release growth hormone.
It works by:
- Stimulating the pituitary gland to release growth hormone
- Helping reduce deep belly fat (especially around organs)
- Supporting metabolism and body composition changes
Because of this, it has been used in certain patients to reduce excess abdominal fat.
How should it be stored?
Store the peptide in the refrigerator or freezer as directed.
After mixing it with liquid, keep it refrigerated (2–8°C) and use within the recommended time.
Avoid repeated freeze-thaw cycles.
Is Tesamorelin FDA-approved?
Yes. Tesamorelin is FDA-approved for reducing excess abdominal fat in patients with HIV-associated lipodystrophy.
What quantity options are available?
It is typically supplied in small-dose vials or kits for medical or research use.